Viewing nowCombinationNomaropin Tablet 5/50 mg
Amlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.

MFDS item code 201504319 · Approved 2015.06.30 · Insurance code 657805610
Treatment of essential hypertension and stage 2 hypertension
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or losartan. It is also applied as initial treatment in stage 2 hypertension patients who require combination therapy to achieve treatment goals. This helps effectively manage blood pressure, reduce the risk of cardiovascular complications, and improve health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, this medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: This medicine is not recommended for patients with reduced effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: This medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older patients: In patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Caution is required when this medication is administered to patients with decreased effective blood volume, for example, in patients taking diuretics, as hypotension may occur. It should not be administered to patients with hypersensitivity to the active ingredients, those who are pregnant or likely to become pregnant, breastfeeding women, patients with severe liver dysfunction, patients with severe aortic stenosis, and patients in shock. Caution is advised for patients with reduced effective blood volume, patients with strict salt restrictions, patients with moderate to severe renal impairment, and patients with hyperkalemia. Adverse reactions such as dizziness, headache, drowsiness, weakness, peripheral edema, dyspepsia, pruritus, palpitations, orthostatic hypotension, dyspnea may occur, and patients should consult a healthcare professional immediately if any abnormal symptoms arise. Since blood pressure may drop causing dizziness while taking this medication, it is advisable to avoid hazardous activities such as working at heights or driving. Patients with liver or kidney impairment may need dosage adjustment, requiring regular check-ups. This medication can raise potassium levels, so when taken with potassium-sparing diuretics or potassium supplements, serum potassium levels should be carefully monitored. Combining with other antihypertensive medications may enhance blood pressure-lowering effects, thus should be used cautiously under the direction of healthcare professionals. Pregnant or breastfeeding women should avoid this medication, and it should be discontinued immediately upon confirmation of pregnancy. Safety and efficacy have not been established for children under 18 years of age, and its use is not recommended. Overdosage can result in severe hypotension and tachycardia, so dosing must be strictly adhered to, and medical assistance should be sought immediately if symptoms occur. This medication should be kept out of reach of children and should not be transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is also advisable to keep it at room temperature, that is, between 1 degree and 30 degrees Celsius. This helps to maintain the effectiveness of the medication for a longer period.
White rectangular film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.